Abstract
Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma1,2. Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug-mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation-altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c-Myc-mediated apoptosis by interacting with conformation-altered Bax. Clusterin promotes c-Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro-apoptotic activities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gleave, M. & Jansen B. Clusterin and IGFBPs as antisense targets in prostate cancer. Ann. NY Acad. Sci. 1002, 95–104 (2003).
Trougakos, I. P. & Gonos, E. S. Clusterin/Apolipoprotein in human aging and cancer. Int. J. Biochem. Cell Biol. 34, 1430–1448 (2002).
Miyake, H., Hara, I., Kamidono, S., Gleave, M. E. & Eto, H. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol. Rep. 10, 469–473 (2003).
Viard, I. et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J. Inv. Derm. 112, 290–296 (1999).
Trougakos, I. P., So, A., Jansen, B., Gleave, M. E. & Gonos, E. S. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Can. Res. 64, 1834–1842 (2004).
Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Can. Cell 4, 209–221 (2003).
Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J. & Dove, W. F. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl Acad. Sci. USA 100, 9530–9535 (2003).
Reed, J. C. & Green, D. R. Remodeling for demolition: Changes in mitochrondrial ultrastructure during apoptosis. Mol. Cell 9, 1–3 (2002).
Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922–2933 (2001).
Zong, W., Lindsten, T., Ross, A. J., MacGregor, G. R. & Thompson, C. B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481–1486 (2001).
Kuwana, T. et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331–342 (2002).
Perez, D. & White, E. TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell 6, 53–63 (2000).
Cheng, E. H. et al. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8, 705–711 (2001).
Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501 (1998).
Arnoult, D. et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J. 22, 4385–4399 (2003).
Wei, M. et al. Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death. Science 292, 727–730 (2001).
Hsu, Y. T. & Youle, R. J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273, 10777–10783 (1998).
Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442 (1988).
Bissonnette, R. P., Echeverri, F., Mahboubi, A. & Green, D. R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552–554 (1992).
Juin, P. et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol. Cell. Biol. 22, 6158–6169 (2002).
Soucie, E. L. et al. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol. Cell. Biol. 21, 4725–4736 (2001).
Eischen, C. M., Roussel, M. F., Korsmeyer, S. J. & Cleveland, J. L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21, 7653–7662 (2001).
You, Z. et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell. Biol. 157, 429–440 (2002).
Guo, B. et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423, 456–461 (2003).
Sawada, M. et al. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nature Cell Biol. 5, 320–329 (2003).
O'Sullivan, J. Whyte, L., Drake, J. & Tenniswood, M. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ. 10, 914–927 (2003).
Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. & Boothman, D. A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590–11600 (2003).
Acknowledgements
We thank Z. You for technical help, A. S. Baldwin for critically reading the manuscript and E. White for inspiring discussion. This study was supported by National Institutes of Health and the US Army Research Office (DAAD19-03-1-0168).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary figures S1, S2, S3, S4 and S5 (PDF 682 kb)
Rights and permissions
About this article
Cite this article
Zhang, H., Kim, J., Edwards, C. et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7, 909–915 (2005). https://doi.org/10.1038/ncb1291
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1291
This article is cited by
-
Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain
BMC Neuroscience (2022)
-
Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis
Cell Death & Disease (2022)
-
Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer
Cell Death & Disease (2022)
-
Glycosylated clusterin species facilitate Aβ toxicity in human neurons
Scientific Reports (2022)
-
Mechanistic implications of altered protein expression in rheumatic heart disease
Heart Failure Reviews (2022)